Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Golimumab Treatment in Ulcerative Colitis
NCT03669029Phase 4Unknown
- Sponsor
- Hospital de Manises
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of golimumab in ulcerative colitis (UC), sponsored by Hospital de Manises. Status: unknown.
02
Drugs
golimumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03669029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03669029.